AI coach could help arthritis patients move better

NCT ID NCT07246811

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an artificial intelligence system can create personalized exercise plans for people with rheumatoid arthritis. 147 patients with mild-to-moderate disease will be split into three groups: one using the AI system via a smartphone app, one using paper exercise instructions, and one receiving standard care. The goal is to see if the AI approach improves knee flexibility, reduces pain, and boosts quality of life over 6 weeks, with follow-up for 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-based exercise prescription system (Yidong Health AI Exercise Prescription System via WeChat mini-program)
What this could lead to
If successful, this could provide a personalized, accessible way for rheumatoid arthritis patients to improve knee mobility and reduce pain at home.
What could go wrong
This is an early-stage, single-center trial with only 147 participants. The AI system may not work for everyone, and results may not apply to patients with more severe disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Rehabilitation Medicine, Peking University People's Hospital

    Beijing, Beijing Municipality, 100000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.